Thursday, 3 October 2013

Renvela


Generic name/Active ingredient: Sevelamer carbonate 800mg
Trade name: Renvela
Dosage form: Tablet
Drug classification: Antidotes
Legal classification: POM
Company: sanofi-aventis
Commonly used for: Control of hyperphosphatemia in adult patients on hemo- or peritoneal dialysis or w/ chronic kidney disease (CKD) not on dialysis w/ serum P ≥1.78 mmol/L. Used w/in the content of a multiple therapeutic regimen that includes Ca supplement, 1,25-dihydroxy vit D3 or 1 of its analogues to control renal bone disease development.